全文获取类型
收费全文 | 86273篇 |
免费 | 6541篇 |
国内免费 | 2564篇 |
专业分类
耳鼻咽喉 | 924篇 |
儿科学 | 1354篇 |
妇产科学 | 1251篇 |
基础医学 | 9067篇 |
口腔科学 | 1728篇 |
临床医学 | 9760篇 |
内科学 | 14655篇 |
皮肤病学 | 752篇 |
神经病学 | 8876篇 |
特种医学 | 1851篇 |
外科学 | 8380篇 |
综合类 | 12190篇 |
一般理论 | 3篇 |
预防医学 | 6262篇 |
眼科学 | 681篇 |
药学 | 10287篇 |
54篇 | |
中国医学 | 5541篇 |
肿瘤学 | 1762篇 |
出版年
2024年 | 84篇 |
2023年 | 1491篇 |
2022年 | 2376篇 |
2021年 | 3834篇 |
2020年 | 3826篇 |
2019年 | 3109篇 |
2018年 | 2940篇 |
2017年 | 3426篇 |
2016年 | 3600篇 |
2015年 | 3535篇 |
2014年 | 6780篇 |
2013年 | 7506篇 |
2012年 | 5664篇 |
2011年 | 6314篇 |
2010年 | 4904篇 |
2009年 | 4617篇 |
2008年 | 4440篇 |
2007年 | 4042篇 |
2006年 | 3548篇 |
2005年 | 2770篇 |
2004年 | 2397篇 |
2003年 | 2027篇 |
2002年 | 1560篇 |
2001年 | 1362篇 |
2000年 | 1140篇 |
1999年 | 960篇 |
1998年 | 776篇 |
1997年 | 666篇 |
1996年 | 620篇 |
1995年 | 518篇 |
1994年 | 490篇 |
1993年 | 403篇 |
1992年 | 412篇 |
1991年 | 354篇 |
1990年 | 374篇 |
1989年 | 328篇 |
1988年 | 278篇 |
1987年 | 220篇 |
1986年 | 212篇 |
1985年 | 247篇 |
1984年 | 226篇 |
1983年 | 137篇 |
1982年 | 154篇 |
1981年 | 116篇 |
1980年 | 134篇 |
1979年 | 114篇 |
1978年 | 86篇 |
1977年 | 70篇 |
1976年 | 61篇 |
1974年 | 30篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Anna Maria Spera 《World Journal of Virology》2022,11(5):275-282
With a 5.3% of the global population involved, hepatitis B virus (HBV) is a major public health challenge requiring an urgent response. After a possible acute phase, the natural history of HBV infection can progress in chronicity. Patients with overt or occult HBV infection can undergo HBV reactivation (HBVr) in course of immunosuppressive treatments that, apart from oncological and hem-atological diseases, are also used in rheumatologic, gastrointestinal, neurological and dermatological settings, as well as to treat severe acute respiratory syndrome coronavirus 2 infection. The risk of HBV reactivation is related to the immune status of the patient and the baseline HBV infection condition. The aim of the present paper is to investigate the risk of HBVr in those not oncological settings in order to suggest strategies for preventing and treating this occurrence. The main studies about HBVr for patients with occult hepatitis B infection and chronic HBV infection affected by non-oncologic diseases eligible for immunosuppressive treatment have been analyzed. The occurrence of this challenging event can be reduced screening the population eligible for immunosuppressant to assess the best strategies according to any virological status. Further prospective studies are needed to increase data on the risk of HBVr related to newer immunomodulant agents employed in non-oncological setting. 相似文献
3.
4.
5.
《Transfusion and apheresis science》2022,61(2):103405
Transfusion-associated graft-versus-host disease (TA-GVHD) is a rare life-threatening complication of blood transfusion caused by donor T cells that escape rejection by the recipient immune system. These donor T cells drive recipient tissue damage in response to host antigens. On the other hand, GVHD occurring after allogeneic hematopoietic cell transplantation (HCT-GVHD) is also caused by donor T cells, but its pathophysiology is more complex and differs due to the effects of tissue damage caused by pre?HCT conditioning and profound immunosuppression. Both TA-GVHD and HCT-GVHD can be fatal; however, mortality is higher with TA-GVHD due to the paucity of treatment options. Here, we compare and summarize the presentation, diagnosis, pathophysiology, prevention, and treatment of TA-GVHD and HCT-GVHD. 相似文献
6.
中国传统运动疗法作为极具特色的康养健身运动疗法,在防病治病中的宝贵价值备受国际康复医学界关注。而慢性筋骨病是骨伤科临床中的常见病、多发病与疑难杂病,临床呈现出“一大五多五高”的特征,成为当前重大的健康问题与临床防治研究课题。本文通过深入探究中国传统运动疗法特点以及其在慢性筋骨病康复中的应用原理、原则及优势作用,提出以传统运动疗法为依托,构建慢性筋骨病防病治病应用方法模式;以三因制宜为指导,构建医院-社区-团体-患者为一体的康复管理模式;以“治未病”工程为支撑,构建慢性筋骨病管理信息资源共享平台模式;为切实提高防、控、治的能力与水平找准抓手与路径,为构建慢性筋骨病康复模式提供新的思路与方向。 相似文献
7.
Osama Y Safdar Rana M Baghdadi Sereen A Alahmadi Bana E Fakieh Amaal M Algaydi 《World Journal of Clinical Pediatrics》2022,11(1):14-26
Whether the underlying mutations are homozygous, heterozygous, or co-inherited with other hemoglobinopathies, sickle cell disease is known to afflict the kidneys, leading to the clinical entity known as sickle cell nephropathy (SCN). Although common, SCN remains diagnostically elusive. Conventional studies performed in the context of renal disorders often fail to detect early stage SCN. This makes the quest for early diagnosis and treatment more challenging, and it increases the burden of chronic kidney disease-related morbidity among patients. Novel diagnostic tools have been employed to overcome this limitation. In this study, we discuss various biomarkers of SCN, including those employed in clinical practice and others recently identified in experimental settings, such as markers of vascular injury, endothelial dysfunction, tubulo-glomerular damage, and oxidative stress. These include kidney injury molecule-1, monocyte chemoattractant protein-1, N-acetyl-B-D-glucosaminidase, ceruloplasmin, orosomucoid, nephrin, and cation channels, among others. Furthermore, we explore the potential of novel biomarkers for refining diagnostic and therapeutic approaches and describe some obstacles that still need to be overcome. We highlight the importance of a collaborative approach to standardize the use of promising new biomarkers. Finally, we outline the limitations of conventional markers of renal damage as extensions of the pathogenic process occurring at the level of the organ and its functional subunits, with a discussion of the expected pattern of clinical and biochemical progression among patients with SCN. 相似文献
8.
9.
《The Journal for Nurse Practitioners》2022,18(2):245-247
Transient stress hyperglycemia in the setting of acute myocardial infarction is a frequent phenomenon. Its transient nature should not dissuade the clinician from management of elevated blood glucose in a patient after an ST-elevation myocardial infarction. This case presents an adult patient after an ST-elevation myocardial infarction with transient stress hyperglycemia and the evidence used to identify optimal pharmacologic management and secondary prevention. 相似文献
10.